| 1 |
The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer |
|
| | Chanukya K. Colonne, Emmanuel J. Favaloro, Leonardo Pasalic | | | Healthcare. 2022; 10(3): 557 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
EphA2, vascular endothelial growth factor, and vascular endothelial growth factor correlate with adverse outcomes and poor survival in patients with glioma |
|
| | Likui Shen,Ran Sun,Shifeng Kan,Zhimin Wang,Zhengquan Yu | | | Medicine. 2021; 100(3): e23985 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Mutational profiling of low-grade gliomas identifies prognosis and immunotherapy-related biomarkers and tumour immune microenvironment characteristics |
|
| | Wen-wen Lin,Guan-yong Ou,Wei-jiang Zhao | | | Journal of Cellular and Molecular Medicine. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis |
|
| | Yi He,Ruijie Liu,Mei Yang,Wu Bi,Liuyin Zhou,Sai Zhang,Jin Jin,Xujun Liang,Pengfei Zhang | | | Frontiers in Oncology. 2021; 11 | | | [Pubmed] [Google Scholar] [DOI] | |
|
